Pro-DexFRA:PDXN -3.60%63 Pretax Margin % is 26.77% as of Mar. 2026, which is 69% above its 10-year median of 15.83. GuruFocus rates FRA:PDXN with a GF Score™ of 63/100 and a GF Value™ of €34.94 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Pro-Dex ranks better than 87.62% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Pro-Dex's Pre-Tax Income for the
three
months ended in Mar. 2026 was €4.62 Mil. Pro-Dex's Revenue for the
three
months ended in Mar. 2026 was €17.26 Mil. Therefore, Pro-Dex's pretax margin for the quarter that ended in Mar. 2026 was 26.77%.
The historical rank and industry rank for Pro-Dex's Pretax Margin % or its related term are showing as below:
FRA:PDXN'
s Pretax Margin % Range Over the Past 10 Years
Min: 4.89 Med: 15.83 Max: 22.68
Current: 21.56
FRA:PDXN's Pretax Margin % is ranked better than 87.62% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.505
vs FRA:PDXN: 21.56
Pro-Dex (FRA:PDXN) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Pro-Dex Pretax Margin % Related Terms
Pro-Dex Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Pro-Dex's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PDXN vs KRMD, EMBC, SMTI: Pretax Margin % Comparison
For the Medical Instruments & Supplies subindustry, Pro-Dex's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pro-Dex Pretax Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pro-Dex's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Pro-Dex's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pro-Dex (FRA:PDXN) has a Pretax Margin % of 26.77% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pro-Dex and its competitors. This is 69% above median its historical median of 15.83. Over the past decade, Pro-Dex's Pretax Margin % has ranged from 4.89 to 22.68. According to the industry distribution chart, Pro-Dex ranks #101 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 12.4%.
Is Pro-Dex's Pretax Margin % too high?
Pro-Dex's current Pretax Margin % of 26.77% is 69% above median its 10-year median of 15.83. Over the past 10 years, this metric has ranged from a low of 4.89 to a high of 22.68. The Medical Devices & Instruments industry median Pretax Margin % is 2.51. Pro-Dex's value of 26.77% is 968.7% above this industry median. Based on the distribution chart, Pro-Dex ranks #101 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Pro-Dex has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pro-Dex's Pretax Margin % compare to KRMD and EMBC?
According to the Medical Devices & Instruments industry distribution chart, Pro-Dex ranks #101 out of 816 companies for Pretax Margin %. This places Pro-Dex in the top 12% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 2.51. Pro-Dex's value of 26.77% is 968.7% above this benchmark. Historically, Pro-Dex's own Pretax Margin % has ranged from 4.89 to 22.68 over the past decade. While the company's 10-year median is 15.83 vs. the industry median of 2.51, Pro-Dex has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Medical Devices & Instruments company?
The median Pretax Margin % among Medical Devices & Instruments companies is 2.51, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pro-Dex's current Pretax Margin % of 26.77% is 968.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Pro-Dex and its competitors. For the Medical Devices & Instruments industry, the median Pretax Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pro-Dex's current Pretax Margin % is 26.77%, which is 69% above median its own 10-year median of 15.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro-Dex stock overvalued right now?
Based on GuruFocus' analysis, Pro-Dex (FRA:PDXN) is currently considered Significantly Overvalued. The stock's GF Value™ is €34.94, compared to a current price of €53.50 — trading 53.1% above its estimated fair value. The current Pretax Margin % is 26.77%, which is 69% above median its 10-year median of 15.83 and 968.7% above the Medical Devices & Instruments industry median of 2.51. Pro-Dex's overall GF Score™ is 63/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Pro-Dex (FRA:PDXN), the current Pretax Margin % is 26.77% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pro-Dex (FRA:PDXN) Overvalued in 2026?
Based on GuruFocus' analysis, Pro-Dex stock appears to be overvalued.
The current stock price of €53.50 is trading 53.1% above its estimated GF Value™ of €34.94.
GuruFocus considers Pro-Dex to be Significantly Overvalued.
Key valuation signals for FRA:PDXN:
Pretax Margin %: 26.77% (69% above median its 10-year median of 15.83)
GF Value™: €34.94 vs. price of €53.50 (53.1% above fair value)
Industry Position: 968.7% above the Medical Devices & Instruments median (#101 of 816)
No single metric tells the full story. See the FRA:PDXN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
63GF Score
Get the complete analysis for FRA:PDXN
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDXN has been successfully added to your 
